Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vandenberghe

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Allergy|October 7, 2022
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromesPeter Valent, Amy D Klion, Florence Roufosse, et al.
Blood|April 22, 2020
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Julie Morscio, Lindy Reunes, et al.
Annals of Hematology|December 30, 2011
Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease courseNatalie Put, Katrien Van Roosbroeck, Peter Konings, et al.
Blood Reviews|February 22, 2025
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMTSimona Pagliuca, Florent Malard, Jarl E Mooyaart, et al.
Blood|October 29, 2005
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 studySylvain Choquet, Veronique Leblond, Raoul Herbrecht, et al.
Clinical Chemistry|June 30, 2022
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing DatasetsHuiwen Che, Tatjana Jatsenko, Liesbeth Lenaerts, et al.
Cancer Cell|January 15, 2020
Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1<sup>+</sup> LeukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.
Hemasphere|May 22, 2025
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalitionAnna Ossami Saidy, Christophe Peczynski, Catherine Thieblemont, et al.
The Lancet Regional Health. Europe|May 13, 2026
A roadmap for supporting the development of advanced therapy medicinal products in a European frameworkJohan Van Eldere, Alessandro Aiuti, Silvia Martin Lluesma, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|June 6, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMTGuillaume Dachy, Jarl E Mooyaart, Ludovic Gabellier, et al.
Allergy|October 7, 2022
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromesPeter Valent, Amy D Klion, Florence Roufosse, et al.
Blood|April 22, 2020
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Julie Morscio, Lindy Reunes, et al.
Annals of Hematology|December 30, 2011
Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease courseNatalie Put, Katrien Van Roosbroeck, Peter Konings, et al.
Blood Reviews|February 22, 2025
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMTSimona Pagliuca, Florent Malard, Jarl E Mooyaart, et al.
Blood|October 29, 2005
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 studySylvain Choquet, Veronique Leblond, Raoul Herbrecht, et al.
Clinical Chemistry|June 30, 2022
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing DatasetsHuiwen Che, Tatjana Jatsenko, Liesbeth Lenaerts, et al.
Cancer Cell|January 15, 2020
Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1<sup>+</sup> LeukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.
Hemasphere|May 22, 2025
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalitionAnna Ossami Saidy, Christophe Peczynski, Catherine Thieblemont, et al.
The Lancet Regional Health. Europe|May 13, 2026
A roadmap for supporting the development of advanced therapy medicinal products in a European frameworkJohan Van Eldere, Alessandro Aiuti, Silvia Martin Lluesma, et al.
Pageof 19